These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17141278)

  • 1. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
    Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
    Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
    Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
    Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
    Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
    Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
    Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOG1: a new susceptibility gene for Brugada syndrome.
    Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
    Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
    Baroudi G; Acharfi S; Larouche C; Chahine M
    Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
    Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
    Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
    Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K
    Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts.
    Herbert E; Chahine M
    Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome].
    Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation-specific effects of lidocaine in Brugada syndrome.
    Clancy CE; Wehrens XH
    Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
    Itoh H; Shimizu M; Takata S; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 May; 16(5):486-93. PubMed ID: 15877619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
    Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
    Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.